Astellas Pharma Inc. announced a nearly $13 million investment into two innovation incubators operated by LabCentral, a premier U.S.-based laboratory facility for next-generation biotech startups. Astellas has infused over $1 billion into the Boston-area life...
Bayer will invest over $30 million, spanning five years, to research and develop new treatments for chronic lung disease as well as a joint lab to broaden Bayer’s presence in the Boston biotech ecosystem. Bayer will join with Partners HealthCare’s founding members...
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok
